Our pan-cancer analysis further substantiated these findings, demonstrating that the downstream effects of CCDC6 and PTK2 on cell function are likely pervasive in cancer beyond just HL, a finding consistent with prior evidence showing their broader roles in cancer progression. This evidence concerns the gene PTK2 and cancer.